(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Lockheed Martin Space Awarded $122.2M Contract, AvidXchange, Cosan, Flywire Get Price Target Boosts

June 03rd, 2023

Lockheed Martin Space, a prominent division of Lockheed Martin Corporation (NYSE: LMT), has secured a significant contract modification worth $122,213,602.  The modification, designated as P00102 under contract FA8810-18-C-0005, aims to facil. Read more

Key Players Set to Reveal Performance Figures: GitLab, SAIC, HealthEquity, Sprinklr, JOANN and Fusion Fuel Green

June 03rd, 2023

Several companies are set to report their financial results on Monday, June 5. GitLab Inc. (Nasdaq: GTLB), a software development platform, will release its first-quarter fiscal year 2024 financial results after the U.S. markets close. The consens. Read more

S&P 500 Boosts Palo Alto Networks, Price Target Hiked: Apple, Tonix Pharmaceuticals, Ryanair, Aflac

June 03rd, 2023

Palo Alto Networks Inc. (Nasdaq: PANW) is set to join the prestigious S&P 500 index, replacing DISH Network Corp. (Nasdaq: DISH), starting from Tuesday, June 20.  The S&P 500 is widely regarded as a benchmark for the U.S. stock market, compri. Read more

The U.S. National Strategy to Counter Antisemitism: Key Actions by Pillar

June 03rd, 2023

JUNE 02, 2023 -  The Biden-Harris Administration released the U.S. National Strategy to Counter Antisemitism on May 25, 2023. The strategy outlines a whole-of-society approach to tackle the scourge of antisemitism in America.. Read more

Jazz Pharma, Zymeworks: Promising Data on Zanidatamab in HER2-Amplified BTC; Positive View on Trade Desk, Kura Sushi and Surgery Partners

June 03rd, 2023

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Zymeworks Inc. (Nasdaq: ZYME) shared encouraging results from the pivotal Phase 2b HERIZON-BTC-01 trial, which assessed the efficacy of Zanidatamab, an investigational bispecific antibody developed on Zymew. Read more

Globus Maritime: Profits, Revenue Decline YoY; Analysts See Opportunity in Paychex, Fluence Energy, Quaker and Movella

June 02nd, 2023

Globus Maritime Limited (Nasdaq: GLBS), a company engaged in the maritime transportation industry, released its first-quarter 2023 report, showcasing the company's financial performance.  The revenue for Q1 2023 amounted to $8.58 mi. Read more

Chijet Motor Debuts on Nasdaq, Market Experts Bullish on Ambrx, FibroGen, Bowlero, REGENXBIO and Kopin

June 02nd, 2023

Chijet Motor Company, Inc. (Nasdaq: CJET) achieved a significant milestone as it officially joined the ranks of NASDAQ-listed companies under the ticker symbol "CJET" on Friday.  With a core focus on the development, manufacturing, sales, and. Read more

FTC Finalizes Order Against Motocross and ATV Parts Maker Cycra for False Made in USA Claims

June 02nd, 2023

Washington D.C. / CRWE PRESS RELEASE / June 2, 2023  -  The Federal Trade Commission has finalized its order against motocross and ATV parts maker Cycra and its officer, Chad James, for falsely claiming that the company&rsquo. Read more

Yunji Soars on Narrower Loss; Ginkgo Bioworks, Xcel Energy Downgraded

June 02nd, 2023

Yunji Inc. (Nasdaq: YJ) experienced a significant surge in its stock price as the company reported a narrower loss in its financial results.  In the first quarter of 2023, Yunji recorded a net loss of RMB22.9 million (US$3.3 million), represe. Read more

LAVA Therapeutics: Janssen Picks Gamma-Delta T-Cell Engager Bispecific Antibody; Chemours, DuPont, and Corteva Reach Agreement in Principle

June 02nd, 2023

LAVA Therapeutics N.V. (Nasdaq: LVTX) has announced a major milestone under the research collaboration initiated in 2020 with Janssen Biotech, Inc., a subsidiary of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ).  Janss. Read more